等待開盤 03-26 09:30:00 美东时间
-0.410
-1.32%
今日重点评级关注:韦德布什:维持Black Diamond Therapeutic"跑赢大市"评级,目标价从13美元升至14美元;花旗:维持Olema Pharmaceuticals"买入"评级,目标价从60美元升至62美元
03-18 10:48
Raymond James analyst RJ Milligan upgrades Essential Properties (NYSE:EPRT) from Outperform to Strong Buy and raises the price target from $35 to $37.
03-17 23:18
今日重点评级关注:LUCID CAPITAL MARKETS:上调INmune Bio评级至"买入" 目标价从2美元升至9美元;Clear Street:维持MoonLake Immunotherapeutics Class A"买入"评级,目标价从45美元升至70美元
03-12 12:34
今日重点评级关注:Oppenheimer:维持Corbus制药控股"跑赢大市"评级,目标价从53美元升至57美元;Canaccord Genuity:维持WAVE Life Sciences"买入"评级,目标价从43美元升至52美元
03-11 12:40
Dividend investors usually start with payout ratios. A lower payout ratio typic...
03-10 23:21
今日重点评级关注:Evercore ISI集团:维持Caribou Biosciences"跑赢大市"评级,目标价从11美元升至13美元;富国银行:上调uniQure评级至"超配",目标价从15美元升至60美元
03-10 15:05
Analysts' ratings for Essential Properties (NYSE:EPRT) over the last quarter va...
03-10 06:01
UBS analyst Michael Goldsmith maintains Essential Properties (NYSE:EPRT) with a Buy and raises the price target from $38 to $40.
03-10 04:32
Essential Properties (EPRT) declares $0.31/share quarterly dividend, in line with previous. Forward yield 3.63% Payable April 14; for shareholders of record March 31; ex-div March 31. See EPRT Dividen...
03-10 04:20
今日重点评级关注:HC Wainwright & Co.:维持Helus Pharma"买入"评级,目标价从55美元升至95美元;HC Wainwright & Co.:维持Compass Pathways"买入"评级,目标价从40美元升至70美元
03-03 20:22